These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20046202)

  • 1. Therapy: Hydroxychloroquine in SLE: old drug, new perspectives.
    Dörner T
    Nat Rev Rheumatol; 2010 Jan; 6(1):10-1. PubMed ID: 20046202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.
    Li XB; Cao NW; Chu XJ; Zhou HY; Wang H; Yu SJ; Ye DQ; Li BZ
    Ann Med; 2021 Dec; 53(1):1687-1695. PubMed ID: 34553648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE.
    Wallace DJ; Linker-Israeli M; Metzger AL; Stecher VJ
    Lupus; 1993 Feb; 2 Suppl 1():S13-5. PubMed ID: 8485565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine: the cornerstone of lupus therapy.
    Ruiz-Irastorza G; Khamashta MA
    Lupus; 2008 Apr; 17(4):271-3. PubMed ID: 18413405
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients.
    Silva JC; Mariz HA; Rocha LF; Oliveira PS; Dantas AT; Duarte AL; Pitta Ida R; Galdino SL; Pitta MG
    Clinics (Sao Paulo); 2013 Jun; 68(6):766-71. PubMed ID: 23778483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarials--the 'real' advance in lupus.
    Wallace DJ
    Lupus; 2001; 10(6):385-7. PubMed ID: 11434570
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic lupus erythematosus therapy. Antimalarials in inflammatory diseases].
    Yebra-Bango M; Tutor-Ureta P
    Rev Clin Esp; 2004 Nov; 204(11):565-6. PubMed ID: 15511401
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of preeclampsia with hydroxychloroquine: a review.
    Abd Rahman R; DeKoninck P; Murthi P; Wallace EM
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):525-529. PubMed ID: 28142291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombovascular events in systemic lupus erythematosus: comment on the article by Jung et al.
    Wallace DJ
    Arthritis Rheum; 2010 Sep; 62(9):2824; author reply 2824-5. PubMed ID: 20872599
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A; West B
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus: review of synthetic drugs.
    Tsang-A-Sjoe MW; Bultink IE
    Expert Opin Pharmacother; 2015; 16(18):2793-806. PubMed ID: 26479437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.
    Cairoli E; Rebella M; Danese N; Garra V; Borba EF
    Lupus; 2012 Oct; 21(11):1178-82. PubMed ID: 22641182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of hydroxychloroquine in lupus pregnancy: the British experience.
    Khamashta MA; Buchanan NM; Hughes GR
    Lupus; 1996 Jun; 5 Suppl 1():S65-6. PubMed ID: 8803914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine: past, present, future.
    Petri M
    Lupus; 1998; 7(2):65-7. PubMed ID: 9541087
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort.
    Molad Y; Gorshtein A; Wysenbeek AJ; Guedj D; Majadla R; Weinberger A; Amit-Vazina M
    Lupus; 2002; 11(6):356-61. PubMed ID: 12139373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial agents and lupus.
    Wallace DJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
    Ugarte A; Danza A; Ruiz-Irastorza G
    Curr Opin Rheumatol; 2018 Sep; 30(5):482-489. PubMed ID: 29870497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
    Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.